BR0212036A - Composições farmacêuticas compreendendo conjugados de polissacarìdeos para a inibição da metástase ou prevenção da recorrência de tumor maligno - Google Patents
Composições farmacêuticas compreendendo conjugados de polissacarìdeos para a inibição da metástase ou prevenção da recorrência de tumor malignoInfo
- Publication number
- BR0212036A BR0212036A BR0212036-4A BR0212036A BR0212036A BR 0212036 A BR0212036 A BR 0212036A BR 0212036 A BR0212036 A BR 0212036A BR 0212036 A BR0212036 A BR 0212036A
- Authority
- BR
- Brazil
- Prior art keywords
- malignant tumor
- pharmaceutical compositions
- inhibiting metastasis
- preventing recurrence
- polysaccharide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001249717 | 2001-08-21 | ||
| PCT/JP2002/008309 WO2003015826A1 (fr) | 2001-08-21 | 2002-08-16 | Compositions pharmaceutiques comprenant des conjugues de polysaccharides permettant l'inhibition des metastases ou la prevention de la recurrence des tumeurs malignes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0212036A true BR0212036A (pt) | 2004-08-17 |
Family
ID=19078678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0212036-4A BR0212036A (pt) | 2001-08-21 | 2002-08-16 | Composições farmacêuticas compreendendo conjugados de polissacarìdeos para a inibição da metástase ou prevenção da recorrência de tumor maligno |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1418947A1 (fr) |
| KR (1) | KR20040027972A (fr) |
| CN (1) | CN100372570C (fr) |
| AR (1) | AR035137A1 (fr) |
| AU (1) | AU2002328093B2 (fr) |
| BR (1) | BR0212036A (fr) |
| CA (1) | CA2457056C (fr) |
| HU (1) | HUP0401351A3 (fr) |
| IL (1) | IL160148A0 (fr) |
| MX (1) | MXPA04001599A (fr) |
| NO (1) | NO20041194L (fr) |
| NZ (1) | NZ530947A (fr) |
| PL (1) | PL368319A1 (fr) |
| RU (1) | RU2275913C2 (fr) |
| TW (1) | TWI313609B (fr) |
| UA (1) | UA75450C2 (fr) |
| WO (1) | WO2003015826A1 (fr) |
| ZA (1) | ZA200400917B (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200306314A (en) * | 2002-04-16 | 2003-11-16 | Tanabe Seiyaku Co | Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation |
| FR2914305B1 (fr) | 2007-03-29 | 2009-07-03 | Proteins & Peptides Man | Dextran fonctionnalise par des amino-acides hydrophobes. |
| EP3693454A1 (fr) | 2008-07-16 | 2020-08-12 | Children's Medical Center Corporation | Dispositif simulateur d'organe comportant des microcanaux et ses procédés d'utilisation et de fabrication |
| AU2012262139B2 (en) * | 2011-06-02 | 2017-02-23 | Children's Medical Center Corporation | Methods and uses for ex vivo tissue culture systems |
| PL221351B1 (pl) | 2012-03-14 | 2016-03-31 | Politechnika Warszawska | Sposób otrzymywania nanocząstek polisacharydowych |
| KR102087017B1 (ko) | 2012-10-11 | 2020-03-10 | 다이이찌 산쿄 가부시키가이샤 | 항체-약물 콘주게이트 |
| EP2910573B1 (fr) * | 2012-10-19 | 2020-02-19 | Daiichi Sankyo Company, Limited | Conjugué anticorps-médicament produit par liaison par l'intermédiaire d'un lieur ayant une structure hydrophile |
| SG11201603960XA (en) | 2014-01-31 | 2016-07-28 | Daiichi Sankyo Co Ltd | Anti-her2 antibody-drug conjugate |
| TWI718144B (zh) | 2015-05-04 | 2021-02-11 | 美商輝瑞股份有限公司 | Ｂ型鏈球菌多醣－蛋白質軛合物、製造軛合物之方法、含軛合物之免疫原性組成物、及其用途 |
| BR112017027690A2 (pt) | 2015-06-29 | 2018-10-09 | Daiichi Sankyo Co Ltd | método para produção de uma composição de conjugado anticorpo-fármaco, e, composição de conjugado anticorpo-fármaco |
| EP3552626A4 (fr) | 2016-12-12 | 2020-06-10 | Daiichi Sankyo Company, Limited | Association d'un conjugué anticorps-médicament et d'un inhibiteur de point de contrôle immunitaire |
| JP6679762B2 (ja) | 2017-01-17 | 2020-04-15 | 第一三共株式会社 | 抗ｇｐｒ２０抗体及び抗ｇｐｒ２０抗体−薬物コンジュゲート |
| TW202330036A (zh) | 2017-05-15 | 2023-08-01 | 日商第一三共股份有限公司 | 抗體-藥物結合物之製造方法 |
| CN117838880A (zh) | 2017-08-31 | 2024-04-09 | 第一三共株式会社 | 制备抗体-药物缀合物的新方法 |
| EP3677589A4 (fr) | 2017-08-31 | 2021-04-21 | Daiichi Sankyo Company, Limited | Procédé amélioré de production d'un conjugué anticorps-médicament |
| CN117815404A (zh) | 2018-05-18 | 2024-04-05 | 第一三共株式会社 | 抗-muc1抗体-药物缀合物 |
| CN109481691A (zh) * | 2018-11-20 | 2019-03-19 | 珠海天香苑生物科技发展股份有限公司 | 吉西他滨-羧甲基多糖共轭物、制备方法及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0640622T3 (da) * | 1993-02-26 | 2000-10-23 | Drug Delivery System Inst Ltd | Polysaccharidderivat og lægemiddelbærer |
| SG50747A1 (en) * | 1995-08-02 | 1998-07-20 | Tanabe Seiyaku Co | Comptothecin derivatives |
| CA2192725C (fr) * | 1995-12-28 | 2004-04-20 | Kenji Tsujihara | Derives de la camptothecine |
| WO1997038727A1 (fr) * | 1996-04-15 | 1997-10-23 | Asahi Kasei Kogyo Kabushiki Kaisha | Composite medicamenteux |
| TW527183B (en) * | 1996-06-06 | 2003-04-11 | Daiichi Seiyaku Co | Drug complex |
| CN1058038C (zh) * | 1996-12-31 | 2000-11-01 | 中国科学院感光化学研究所 | 低收缩性光固化涂层材料及其制法和用途 |
| EA003398B1 (ru) * | 1998-05-22 | 2003-04-24 | Дайити Фармасьютикал Ко., Лтд. | Лекарственный комплекс c полимерным носителем |
-
2002
- 2002-08-14 TW TW091118260A patent/TWI313609B/zh not_active IP Right Cessation
- 2002-08-15 AR ARP020103077A patent/AR035137A1/es unknown
- 2002-08-16 KR KR10-2004-7002566A patent/KR20040027972A/ko not_active Application Discontinuation
- 2002-08-16 HU HU0401351A patent/HUP0401351A3/hu unknown
- 2002-08-16 EP EP02762786A patent/EP1418947A1/fr not_active Withdrawn
- 2002-08-16 IL IL16014802A patent/IL160148A0/xx unknown
- 2002-08-16 NZ NZ530947A patent/NZ530947A/en not_active IP Right Cessation
- 2002-08-16 UA UA2004032071A patent/UA75450C2/uk unknown
- 2002-08-16 CA CA002457056A patent/CA2457056C/fr not_active Expired - Fee Related
- 2002-08-16 WO PCT/JP2002/008309 patent/WO2003015826A1/fr active IP Right Grant
- 2002-08-16 MX MXPA04001599A patent/MXPA04001599A/es unknown
- 2002-08-16 CN CNB028163176A patent/CN100372570C/zh not_active Expired - Fee Related
- 2002-08-16 AU AU2002328093A patent/AU2002328093B2/en not_active Ceased
- 2002-08-16 BR BR0212036-4A patent/BR0212036A/pt not_active IP Right Cessation
- 2002-08-16 PL PL02368319A patent/PL368319A1/xx not_active Application Discontinuation
- 2002-08-16 RU RU2004108141/15A patent/RU2275913C2/ru not_active IP Right Cessation
-
2004
- 2004-02-04 ZA ZA200400917A patent/ZA200400917B/en unknown
- 2004-03-19 NO NO20041194A patent/NO20041194L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2457056A1 (fr) | 2003-02-27 |
| ZA200400917B (en) | 2004-08-25 |
| RU2004108141A (ru) | 2005-04-20 |
| AU2002328093B2 (en) | 2005-05-05 |
| IL160148A0 (en) | 2004-07-25 |
| CN1545423A (zh) | 2004-11-10 |
| PL368319A1 (en) | 2005-03-21 |
| KR20040027972A (ko) | 2004-04-01 |
| NO20041194L (no) | 2004-03-19 |
| CA2457056C (fr) | 2008-07-22 |
| TWI313609B (en) | 2009-08-21 |
| NZ530947A (en) | 2006-04-28 |
| CN100372570C (zh) | 2008-03-05 |
| MXPA04001599A (es) | 2004-07-08 |
| UA75450C2 (en) | 2006-04-17 |
| EP1418947A1 (fr) | 2004-05-19 |
| AR035137A1 (es) | 2004-04-14 |
| WO2003015826A1 (fr) | 2003-02-27 |
| RU2275913C2 (ru) | 2006-05-10 |
| HUP0401351A3 (en) | 2011-02-28 |
| HUP0401351A2 (hu) | 2004-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0212036A (pt) | Composições farmacêuticas compreendendo conjugados de polissacarìdeos para a inibição da metástase ou prevenção da recorrência de tumor maligno | |
| EP1430061A4 (fr) | Compose d'inclusion contenant des derives de cucurbituril en tant que molecule receptrice et composition pharmaceutique les contenant | |
| ATE377597T1 (de) | Anilinochinazoline als protein-tyrosin- kinasehemmer | |
| BR9807824A (pt) | Derivados de n-hidróxi-beta-sulfonil-propionamida e seu uso como inibidores de metaloproteinases de matriz | |
| NO20042298L (no) | Farmasoytiske preparater og deres anvendelser | |
| TR199900049T2 (xx) | Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler. | |
| TR200101032T2 (tr) | Bitkilerdeki sağaltıcı yönden aktif proteinler. | |
| BR0215240A (pt) | Derivados de calcona e seu uso no tratamento de doenças | |
| TR200200717T2 (tr) | Terapötik kinazolin türevleri. | |
| BR0115427A (pt) | Composto, composição farmacêutica, métodos para inibir a liberação de peptìdeo beta-amilóide e/ou sua sìntese, para tratar a doença de alzheimer, e para prevenir a doença e o progresso da doença de alzheimer, e, uso de um composto | |
| EE200400033A (et) | Vähelahustuvaid ja/või happetundlikke ravimeid janeutraliseeritud happelisi polümeere sisaldavad farmatseutilised kompositsioonid | |
| ATE277929T1 (de) | Immunsuppressive wirkungen von pteridinderivaten | |
| BR9714358A (pt) | Derivados de n- (arila/heteroarila) amino ácido,composições farmacêuticas compreendendo os mesmos, e métodos para a inibição de liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos | |
| BR0315580A (pt) | Derivados de metileno uréia | |
| BRPI0410669A (pt) | inibidores de caspase e usos dos mesmo | |
| BR0314797A (pt) | Derivados da pirimidineamida e o uso dos mesmos | |
| WO2000045800A3 (fr) | Effets immunosuppresseurs des derives de pteridine | |
| ATE422356T1 (de) | Pharmazeutische zubereitungen | |
| ATE249842T1 (de) | Zielgerichte arzneimittel abgabe für zulphonamide-derivate | |
| BR0014378A (pt) | Derivados de ácido indolil-3-glioxìlico tendo propriedades terapeuticamente valiosas | |
| TR199900336T2 (xx) | EAA antagonistleri olarak tetrahidrokinolin t�revleri. | |
| BR0208017A (pt) | Combinação compreendendo combretastatina e agentes anticâncer | |
| BR0008297A (pt) | Uso de 4,6-o-(benzilideno-d1) -d-glucopiranose, 4,6-o-benzilideno-l-glucopiranose, e/ou 4,6-o-(benzilideno-d1) -l-glucopiranose, ou um sal farmacêutico aceitável dos mesmos, derivado de benzaldeìdo composição farmacêutica, e, processo para a fabricação da mesma | |
| WO2001042243A3 (fr) | Inhibiteurs de proteine kinase | |
| BRPI0413384A (pt) | inibidores da proteìna farnesil transferase como agentes antitumores |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: MITSUBISHI TANABE PHARMA CORPORATION (JP) Free format text: ALTERADO DE: TANABE SEIYAKU CO., LTD. |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE(S) |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2116 DE 26/07/2011. |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 47/61 (2017.01), A61K 47/65 (2017.01), A61P 3 |